| BID | 71.75 | ASK | 71.94 | ||
| Open | 72.59 | Previous Close | 72.83 | ||
| Pre-Market | - | After-Market | 71.75 | ||
| - - | - -% |
| Target Price | 81.25 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 13.24 | Finscreener Ranking | ★★★★ 54.12 | |
| Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 47.41 | |
| Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★+ 58.01 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
| Market Cap | 3.72B | Earnings Rating | Strong Sell | |
| Price Range Ratio 52W % | 64.53 | Earnings Date | 29th Apr 2021 |
Today's Price Range 70.2573.00 | 52W Range 20.6799.83 | 5 Year PE Ratio Range -25.10-3.00 |
Summary:
Neutral
| Technical Indicators: | Sell |
| Moving Averages: | Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 1.92% | ||
| 1 Month | 8.79% | ||
| 3 Months | -11.16% | ||
| 6 Months | 32.98% | ||
| 1 Year | 227.46% | ||
| 3 Years | 725.66% | ||
| 5 Years | 1 301.37% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -51.00 | |||
ROE last 12 Months | -9.71 | |||
ROA (5Y Avg) | -14.58 | |||
ROA last 12 Months | -7.01 | |||
ROC (5Y Avg) | -72.61 | |||
ROC last 12 Months | -9.91 | |||
Return on invested Capital Q | -1.21 | |||
Return on invested Capital Y | -9.04 | |||
Assets Turnover | 0.60 | |||
Receivables Turnover | 4.90 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -167.60 | ||||
| 12.71 | ||||
| 23.72 | ||||
| 94.70 | ||||
| 148.40 | ||||
| 0.72 | ||||
| 17.42 | ||||
| 5.36 | ||||
| 3.44B | ||||
| Forward PE | 234.66 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 3.70 | ||||
| 3.90 | ||||
| 0.05 | ||||
| 0.07 | ||||
| - | ||||
| Leverage Ratio | 1.30 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 67.20 | ||||
| -14.80 | ||||
| -10.30 | ||||
| -62.50 | ||||
| -8.19 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 153.81M | ||||
| 2.97 | ||||
| 56.81 | ||||
| 47.50 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2020 | -0.12 | -0.07 | 41.67 |
| Q03 2020 | -0.19 | -0.06 | 68.42 |
| Q02 2020 | -0.17 | -0.15 | 11.76 |
| Q01 2020 | -0.13 | -0.14 | -7.69 |
| Q04 2019 | -0.16 | -0.11 | 31.25 |
| Q03 2019 | -0.16 | -0.04 | 75.00 |
| Q02 2019 | -0.12 | -0.19 | -58.33 |
| Q01 2019 | -0.15 | -0.18 | -20.00 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 3/2021 QR | -0.14 | -55.56 | Negative |
| 6/2021 QR | -0.11 | -83.33 | Negative |
| 12/2021 FY | -0.36 | -157.14 | Negative |
| 12/2022 FY | 0.30 | -23.08 | Negative |
| Next Report Date | 29th Apr 2021 |
| Estimated EPS Next Report | -0.14 |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 300.21K |
| Shares Outstanding | 51.82M |
| Trades Count | 6.29K |
| Dollar Volume | 162.12M |
| Avg. Volume | 799.38K |
| Avg. Weekly Volume | 391.69K |
| Avg. Monthly Volume | 686.00K |
| Avg. Quarterly Volume | 810.44K |
CareDx Inc. (NASDAQ: CDNA) stock closed at 71.75 per share at the end of the most recent trading day (a -1.48% change compared to the prior day closing price) with a volume of 316.31K shares and market capitalization of 3.72B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 475 people. CareDx Inc. CEO is Reginald Seeto.
The one-year performance of CareDx Inc. stock is 227.46%, while year-to-date (YTD) performance is -0.97%. CDNA stock has a five-year performance of 1301.37%. Its 52-week range is between 20.67 and 99.83, which gives CDNA stock a 52-week price range ratio of 64.53%
CareDx Inc. currently has a PE ratio of -167.60, a price-to-book (PB) ratio of 12.71, a price-to-sale (PS) ratio of 23.72, a price to cashflow ratio of 94.70, a PEG ratio of 2.32, a ROA of -7.01%, a ROC of -9.91% and a ROE of -9.71%. The company’s profit margin is -8.19%, its EBITDA margin is -10.30%, and its revenue ttm is $153.81 Million , which makes it $2.97 revenue per share.
Of the last four earnings reports from CareDx Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. CareDx Inc.’s next earnings report date is 29th Apr 2021.
The consensus rating of Wall Street analysts for CareDx Inc. is Strong Buy (1), with a target price of $81.25, which is +13.24% compared to the current price. The earnings rating for CareDx Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CareDx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
CareDx Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.75, ATR14 : 7.48, CCI20 : -138.44, Chaikin Money Flow : -0.11, MACD : -4.78, Money Flow Index : 42.21, ROC : -19.53, RSI : 37.12, STOCH (14,3) : 25.09, STOCH RSI : 0.33, UO : 41.73, Williams %R : -74.91), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CareDx Inc. in the last 12-months were: Fred E. Cohen (Option Excercise at a value of $306 005), George W. Bickerstaff (Sold 30 000 shares of value $1 270 560 ), Michael Brian Bell (Option Excercise at a value of $664 737), Michael Brian Bell (Sold 89 710 shares of value $3 225 519 ), Michael D. Goldberg (Sold 50 000 shares of value $2 702 978 ), Peter Maag (Option Excercise at a value of $1 211 078), Peter Maag (Sold 539 600 shares of value $20 924 033 ), Ralph Snyderman (Sold 12 000 shares of value $1 066 513 ), Reginald Seeto (Sold 19 067 shares of value $1 483 501 ), Sasha King (Option Excercise at a value of $1 205 031), Sasha King (Sold 152 104 shares of value $7 539 278 ), William A. Hagstrom (Option Excercise at a value of $101 600), William A. Hagstrom (Sold 40 000 shares of value $1 419 545 )
CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey, and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.
CEO: Reginald Seeto
Telephone: +1 415 287-2300
Address: 1 Tower Place, South San Francisco 94080, CA, US
Number of employees: 475
